Actualizaciones Recientes
-
Rucaparib: A Powerful PARP Inhibitor for Cancer PatientsRucaparib is a potent PARP (Poly ADP-Ribose Polymerase) inhibitor that has revolutionized cancer treatment, particularly for patients with advanced ovarian, prostate, and other BRCA-mutated cancers. By inhibiting the PARP enzyme, Rucaparib prevents cancer cells from repairing their damaged DNA, leading to cell death and tumor reduction. This targeted mechanism enhances its effectiveness while...0 Commentarios 0 Acciones 173 Views 0 Vista previaPlease log in to like, share and comment!
-
0 Commentarios 0 Acciones 52 Views 0 Vista previa
Quizás te interese…